Cargando…
Development of a high-throughput homogeneous AlphaLISA drug screening assay for the detection of SARS-CoV-2 Nucleocapsid
The coronavirus disease 2019 (COVID-19) pandemic caused by Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is in urgent need of therapeutic options. High-throughput screening (HTS) offers the research field an opportunity to rapidly identify such compounds. In this work, we have develop...
Autores principales: | Gorshkov, Kirill, Chen, Catherine Z., de la Torre, Juan Carlos, Martinez-Sobrido, Luis, Moran, Thomas, Zheng, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444285/ https://www.ncbi.nlm.nih.gov/pubmed/32839774 http://dx.doi.org/10.1101/2020.08.20.258129 |
Ejemplares similares
-
Development of a High-Throughput Homogeneous AlphaLISA
Drug Screening Assay for the Detection of SARS-CoV-2 Nucleocapsid
por: Gorshkov, Kirill, et al.
Publicado: (2020) -
Development of
a Cell-Based AlphaLISA Assay for High-Throughput
Screening for Small Molecule Proteasome Modulators
por: Staerz, Sophia D., et al.
Publicado: (2023) -
Comparison of AlphaLISA and RIA assays for measurement of wool cortisol concentrations
por: Peric, T., et al.
Publicado: (2020) -
Development of an AlphaLISA assay for sensitive and accurate detection of influenza B virus
por: Zong, Huijun, et al.
Publicado: (2023) -
SARS-CoV-2 Nucleocapsid Protein TR-FRET Assay
Amenable to High Throughput Screening
por: Gorshkov, Kirill, et al.
Publicado: (2022)